Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1
Author:
Funder
Natural Science Foundation of Shaanxi Province
China Postdoctoral Science Foundation
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference35 articles.
1. Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia;Budak-Alpdogan;Am. J. Hematol,1999
2. First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib;Wei;J. Hematol. Oncol,2010
3. Clinical resistance to STI571 cancer therapy caused by BCR-ABL gene mutation or amplification;Gorre;Science,2001
4. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia;Shah;Cancer Cell,2002
5. Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells;Nimmanapalli;Blood,2003
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HDAC inhibitors: Promising agents for leukemia treatment;Biochemical and Biophysical Research Communications;2023-11
2. Isoliquiritigenin from licorice flavonoids attenuates NLRP3-mediated pyroptosis by SIRT6 in vascular endothelial cells;Journal of Ethnopharmacology;2023-03
3. Combined effects on leukemia cell growth by targeting sphingosine kinase 1 and sirtuin 1 signaling;Experimental and Therapeutic Medicine;2020-10-27
4. Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells;Biological and Pharmaceutical Bulletin;2020-10-01
5. Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line;Purinergic Signalling;2020-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3